4/17/2026 10:00:23 AM Ten takeaways from the EDPB's draft guidelines on scientific research By Hannah Crowther I have now waded through all 66 pages of the European Data Protection Board’s draft guidelines on scientific research, and here’s a...
4/17/2026 9:33:44 AM Podcast: A conversation with Anya By Ellie Handy In this episode, Ellie Handy is joined by Dr Chen Mao Davies, Founder and CEO of Anya, to explore what it really takes to bring a digital...
4/15/2026 2:12:07 PM A new chapter for Women’s Health: Reform, funding and opportunity By Anna Honey The UK government published a renewed Women’s Health Strategy for England today, signalling a continued push to address long-standing...
3/24/2026 2:09:36 PM Biotech Review of the Year Issue 13 - out now! By Charlie French Ellen Lambrix Aida Tohala Erik Müürsepp +1 more... Show less We’re pleased to share the 13th edition of our Biotech Review of the Year, bringing together practical legal, regulatory and commercial...
3/24/2026 1:47:23 PM Competition authorities in Europe target ‘killer acquisitions’ – what biotech companies need to know By Sophie Lawrance Victoria Yuan This article is part of our Biotech Review of the Year - Issue 13 publication. Competition authorities are increasingly targeting...
3/20/2026 3:41:51 PM Changes announced to the UK FDI mandatory notification regime By Stephen Smith Victoria Yuan Nick Cross Oliver Alsop +1 more... Show less The UK government announces changes to the mandatory notification regime under the National Security and Investment Act. What are the...
2/20/2026 10:13:57 AM Podcast: Patenting trends in women’s health By Maria Ryan Melissa Dix In this episode of our Spotlight on Women's Health and Innovation podcast, Maria Ryan and Melissa Dix explore how patenting trends offer...
2/16/2026 10:21:16 AM Chinese biotech and the shift in global pharma deals By James Johnston Claire Smith The historical western approach of relying on internally-developed blockbuster drugs to drive growth is now under strain. Patent expiries...
2/16/2026 9:14:09 AM Women’s Health in focus: key themes for 2026 By Laura Harwood Ellie Handy The women’s health sector is undergoing significant transformation. A major driving force for this is the evolution of AI and the impact...
2/13/2026 10:49:00 AM Off the cliff, into the deal room: pharma M&A in 2026 and beyond By Mohammad Aljamal The global biopharmaceutical industry entered 2026 facing one of the largest waves of patent expirations in its history. The potential...
1/28/2026 4:35:53 PM A forensic dissection of revised classification Rule 11 – is there any basis for expecting software down classification? By Ellie Handy At the time the Commission published its “Proposal for a regulation to simplify rules on medical and in vitro diagnostic devices”, making...
1/16/2026 2:38:37 PM Medical device simplification in detail: orphan and breakthrough device designations By Jamie Hatzel We wrote recently about the European Commission’s proposals to simplify the EU Medical Device Regulation (“MDR”)[1] and EU In Vitro...